Walled Lake Planning & Wealth Management, LLC Denali Therapeutics Inc. Transaction History

Walled Lake Planning & Wealth Management, LLC

$246 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$29.0 - $47.27 $145,580 - $237,295	-5,020 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$53.8 - $81.53 $44,116 - $66,854	820 Added 19.52%	5,020 $287,000
Q4 2020 Feb 19, 2021	BUY	$36.89 - $93.56 $44,268 - $112,272	1,200 Added 40.0%	4,200 $352,000
Q3 2020 Nov 13, 2020	BUY	$23.13 - $38.84 $69,390 - $116,520	3,000 New	3,000 $107,000

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

Baillie Gifford & CO

13.3M
Shares

$287 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.2M
Shares

$283 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

11.2M
Shares

$240 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.7M
Shares

$231 Million
0.06% of portfolio
Capital Research Global Investors Los Angeles, CA

7.91M
Shares

$170 Million
0.05% of portfolio

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Walled Lake Planning & Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walled Lake Planning & Wealth Management, LLC with notifications on news.

Account